domingo, 3 de febrero de 2019

Multi-target drugs should be in the pharma pipeline along with precision drugs - STAT

Multi-target drugs should be in the pharma pipeline along with precision drugs - STAT

First Opinion

Multi-target drugs should be in the pharma pipeline along with precision drugs

By HARRIS A. GELBARD


QUINN ROONEY/GETTY IMAGES
The pharmaceutical industry shouldn't overlook the development of multi-target drugs in its race to develop precision drugs that take aim at single targets.

No hay comentarios: